Buflomedil is a vasoactive drug used to treat claudication or the symptoms of peripheral arterial disease. It is currently not approved by the FDA for use in the United States. Currently available as trade name tablet Loftyl
This drug might be suspended from marketing in the European Union, because of concerns about severe neurological and cardiac toxicity.12 In its press release dated 17 November 2011 EMA suggested that doctors "should stop using buflomedil and consider alternative treatment options".
Various adverse effects have been reported to the FDA.3